Pyogenic Granuloma in Ten Children Treated with Topical Imiquimod
Tritton SM et al. - One child required a prolonged treatment course, and one progressed to surgical excision when prolonged treatment failed. There were no systemic side effects noted in any of the patients and no recurrence noted with resolution sustained over an average of 9.6 months of follow-up. Imiquimod is a safe, cost-effective, and clinically effective management option in the treatment of pyogenic granuloma. [more...]
|
|
|
